Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Important Risk Factors of Liver Cirrhosis in Hiv and Hepatitis C Coinfected Patients: A Systematic Review Publisher



Mehraeen E1 ; Janfaza N2 ; Shahidi R3 ; Afzalian A4 ; Varshochi S4 ; Jashaninejad R5, 6 ; Pashaei A7 ; Tantuoyir MM4, 8 ; Camara M9 ; Paranjkhoo P10 ; Parmoon Z5 ; Elnaz S4 ; Salmani R11 ; Matini P12 Show All Authors
Authors
  1. Mehraeen E1
  2. Janfaza N2
  3. Shahidi R3
  4. Afzalian A4
  5. Varshochi S4
  6. Jashaninejad R5, 6
  7. Pashaei A7
  8. Tantuoyir MM4, 8
  9. Camara M9
  10. Paranjkhoo P10
  11. Parmoon Z5
  12. Elnaz S4
  13. Salmani R11
  14. Matini P12
  15. Mirzapour P5
  16. Ebrahimi H13
  17. Moradi A4
  18. Seyed Alinaghi S5
  19. Jahanfar S14
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran
  2. 2. Department of Internal Medicine, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
  4. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  7. 7. School of Nursing, University of British Columbia, Vancouver, Canada
  8. 8. Biomedical Engineering Unit, University of Ghana Medical Center (UGMC), Accra, Ghana
  9. 9. Edward Francis Small Teaching Hospital, Banjul, Gambia
  10. 10. Turpanjian College of Health Sciences, American University of Armenia, Yerevan, 0019, Armenia
  11. 11. Department of Midwifery, Khalkhal University of Medical Sciences, Khalkhal, Iran
  12. 12. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  13. 13. Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  14. 14. Department of Public Health and Community Medicine, Tufts University School of Medicine, United States

Source: Open AIDS Journal Published:2024


Abstract

Introduction: Hepatitis C virus (HCV) is the leading cause of chronic hepatitis and liver fibrosis. Due to shared modes of transmission with human immunodeficiency virus (HIV), HIV-HCV coinfection is also common worldwide. Multiple studies have shown that the rates of liver fibrosis and associated complications increase considerably in this sub-population compared to a single HCV infection. Thus, in this study, we aimed to conduct a systematic review of possible associated important risk factors of accelerated liver cirrhosis among HIV-HCV coinfected subjects. Methods: A systematic review of published studies relevant to the main risk factors of liver cirrhosis progression in HIV and hepatitis C coinfected patients was performed using databases of PubMed, Web of Science, Scopus, and Embase were searched using keywords and their combinations. We retrieved all the relevant papers and reports published in English till 27 June 2022, which were examined by applying inclusion/exclusion criteria for data extraction after a two-step screening process. Results: The long-term or chronic hepatitis C and HIV coinfection is a substantial risk factor for Cirrhosis. Primary etiologies identified causing fibrosis, and the rapid progression of Cirrhosis in HIV/HCV coinfected patients include high-risk alcohol consumption, chronic elevation of ALT, AST, Aspartate Aminotransferase to Platelet Ratio Index (APRI) and Gamma-glutamyl Transferase (GGT), Body Mass Index (BMI), older age, high HIV and HCV viral loads, lower CD4+ count (<250/mm3), and male gender. Comorbidities such as diabetes, hypertension, hyperlipidemia, and high visceral fat area are suggested etiologies of cirrhosis. Conclusion: The results showed that HIV accelerates the progression of HCV-related liver disease independent of its effect on the immune system. This effect is somehow dependent on age, gender, BMI, duration of HIV infection, and CD4 count. © 2024 The Author(s). Published by Bentham Open.